According to Cytek Biosciences's latest financial reports the company's current revenue (TTM) is $0.19 B. In 2022 the company made a revenue of $0.16 B an increase over the years 2021 revenue that were of $0.12 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.19 B | 17.67% |
2022 | $0.16 B | 28.2% |
2021 | $0.12 B | 37.82% |
2020 | $92.83 M |